Dr. Monaghan's Biographical Information

Daniel Monaghan DANIEL MONAGHAN
PhD, Biological Sciences, 1985
University of California, Irvine

Positions and Employment

July 2000-present

Professor, Pharmacology and Experimental Neuroscience
University of Nebraska Medical Center, Omaha, NE
July 1993-June 2000 Associate Professor, Pharmacology and Experimental Neuroscience
University of Nebraska Medical Center, Omaha, NE
June 1989-June 1993 Assistant Professor, Pharmacology and Experimental Neuroscience
University of Nebraska Medical Center, Omaha, NE
June 1988-June 1989

Assistant Professor, Surgery
University of California, Irvine Medical Center, Irvine, CA
September 1988-December 1988

Instructor, School of Biology
University of California, Irvine
June 1987-June 1988

Assistant Research, Surgery, Division of Neurological Surgery
University of California, Irvine Medical Center, Irvine, CA

Assistant Research Psychobiologist, Psychobiology
University of California, Irvine

Other Experience and Professional memberships

Invited Grant Reviewer:

  • Veterans Administration
  • New Zealand Medical Research Council
  • National Science Foundation
  • March of Dimes
  • City University of New York
  • National Institutes of Health
  • National Institute of Mental Health
  • Qatar Government

Editorial Boards:

  • Journal of Pharmacology and Experimental Therapeutics (1995-1997)
  • Journal of Neurochemistry (1998-2005)
  • Journal of Biomedicine and Biotechnology 2009-

Evaluation Panel Member:

  • Current Drugs; (1998-present)

Memberships in Professional Societies:

  • American Soc. Neurochemistry
  • American Soc. Pharmacology and Experimental Therapeutics
  • International Soc. Neurochemistry
  • Society for Neuroscience

 

Patents

  • NMDA receptor blockers for the prevention of atherosclerosis.
  • PPDA, a novel NMDA receptor antagonist of unique subtype selectivity.(joint patent between Dr. David Jane, Univ. Bristol and Dan Monaghan)
  • N-Methyl-D-aspartate receptor blockers for the prevention of congenital cardiovascular malformations.

Books and book chapters

Books:
Monaghan, D.T. and Wenthold, R.J. The Ionotropic Glutamate Receptors Humana Press, Totowa NJ, 1997.

Recent Book Chapters
Monaghan, D. and Jane, D. E. Pharmacology of the NMDA Receptor. In: Biology of the NMDA Receptor; Ed. A. VanDongen, CRC Press, pp. 257-281 (2009).

Bleakman, D., Alt, A.J., Lodge, D.J., Monaghan, D.T., Jane, D.E., and Nisenbaum, E.S. Excitatory amino acids: Ionotropic glutamate receptors. (Chapter 10) In: The Handbook of Contemporary Neuropharmacology; Editors: D. Sibley, I. Hanin, M. Kuhar, and P. Skolnick. John Wiley & Sons, Inc., Hoboken. (2007).

Monaghan DT, Boyle J, Bean L, Gautam V, and Jane, DE Structure and function of NMDA Receptor Channels. In: Biophysical aspects of ligand-gated ion channel receptor superfamilies. Ed.: Arias; Research Signpost. (2006) pp 259

Monaghan, D.T., More J.C.A., Feng, B., and Jane, D. Glutamate Receptors: Ionotropic., In Dopamine and glutamate in psychiatric disorders. Eds. W. J. Schmidt and M..A. Reith. Humana Press, pp. 415-478 (2005).

Publications on PubMed

top of page

 

Return to Dr. Monaghan's home page
Visit Dr. Monaghan's laboratory